Abstract
The efficacy and safety of pramipexole have been reported both in the treatment of unipolar/bipolar depression and anxiety/depression in patients with Parkison disease. But, there is no evidence for its clinical effect in seasonal depressive disorder. In this case report, the patient with seasonal depression responded to pramipexole is presented.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
